Prelude Capital Management’s Energen EGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-118,718
Closed -$10.2M 2394
2018
Q3
$10.2M Buy
118,718
+107,860
+993% +$8.21M 0.59% 25
2018
Q2
$791K Buy
10,858
+4,618
+74% +$303K 0.05% 395
2018
Q1
$392K Buy
+6,240
New +$350K 0.03% 505
2017
Q3
Sell
-1,500
Closed -$74K 2051
2017
Q2
$74K Buy
+1,500
New +$80K 0.01% 873
2017
Q1
Sell
-46,472
Closed -$2.68M 1933
2016
Q4
$2.68M Buy
46,472
+1,091
+2% +$62.1K 0.32% 84
2016
Q3
$2.62M Sell
45,381
-37,227
-45% -$1.94M 0.27% 70
2016
Q2
$3.98M Buy
+82,608
New +$3.6M 0.56% 31
2015
Q4
Sell
-478
Closed -$24K 1824
2015
Q3
$24K Sell
478
-2,182
-82% -$118K ﹤0.01% 1227
2015
Q2
$182K Buy
2,660
+1,960
+280% +$136K 0.03% 654
2015
Q1
$46K Sell
700
-800
-53% -$51.5K 0.01% 1332
2014
Q4
$96K Buy
+1,500
New +$95K 0.01% 1020
2014
Q3
Sell
-4,139
Closed -$368K 2276
2014
Q2
$368K Buy
4,139
+1,139
+38% +$95.8K 0.05% 500
2014
Q1
$242K Buy
+3,000
New +$225K 0.03% 661
2013
Q4
Sell
-34,484
Closed -$2.63M 2072
2013
Q3
$2.63M Buy
+34,484
New +$2.23M 0.43% 29

Other funds holding EGN

Prelude Capital Management's EGN Position: Q4 2018 in Review

Prelude Capital Management sold out of Energen (EGN) in Q4 2018, closing a stake of 118,718 shares — an estimated $10.2M sold.

Prelude Capital Management first reported a position in EGN in Q3 2013 and held it in 14 quarters. The position peaked at $10.2M in Q3 2018. 4 funds tracked by Wall St. Rank hold EGN as of Q4 2018.

  • Prelude Capital Management reported no remaining Energen position as of Q4 2018 after selling out during the quarter.
  • Prelude Capital Management sold 118,718 Energen shares in Q4 2018, an estimated $10.2M.
  • Prelude Capital Management first reported a position in Energen in Q3 2013 and held it in 14 quarters.
  • Prelude Capital Management's Energen position peaked at $10.2M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Energen as of Q4 2018.

Based on Prelude Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.